Related Experiment Videos
Alpha 1-microglobulin: clinical laboratory aspects and applications
Joris Penders1, Joris R Delanghe
1Department of Clinical Chemistry, University Hospital Ghent-2P8, De Pintelaan 185, B-9000 Ghent, Belgium.
Summary
Alpha 1-microglobulin (A1M) is a promising urinary marker for early detection of kidney and urinary tract disorders. Its measurement offers a non-invasive diagnostic alternative for various conditions, aiding in patient monitoring.
Area of Science:
- Biochemistry
- Clinical Diagnostics
- Nephrology
Background:
- Urinary microproteins are crucial for non-invasive early detection of renal abnormalities.
- Alpha 1-microglobulin (A1M) is an immunomodulatory protein with potential clinical applications.
- A1M shows promise as a marker for evaluating tubular function.
Purpose of the Study:
- To conduct a systematic literature review on Alpha 1-microglobulin (A1M).
- To emphasize the clinical diagnostic utility and laboratory aspects of A1M.
- To explore A1M as a diagnostic marker for renal and urological pathologies.
Main Methods:
- Systematic review of peer-reviewed literature.
- Literature search conducted up to November 2003.
- Emphasis on clinical diagnostic utility and laboratory aspects of A1M.
Main Results:
- A1M is a 27-kDa glycoprotein found in body fluids, with roles in bacterial adhesion and inhibiting renal lithogenesis.
- A1M is stable, not an acute phase protein, and measurable via sensitive immunoassays.
- Altered A1M levels indicate impaired liver/kidney function, HIV, or mood disorders.
Conclusions:
- Urinary A1M serves as a non-invasive, cost-effective diagnostic tool for urinary tract disorders.
- A1M aids in early detection of tubular disorders like heavy metal intoxication, diabetic nephropathy, and pyelonephritis.
- International standardization of A1M measurement is still needed for broader clinical application.